LC

Lightchain Capital

North America, Missouri, United States, St Louis

Description

Lightchain Capital focuses investments on early-stage life sciences companies.

Investor Profile

Lightchain Capital has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Enterprise Applications, Information Technology.

Stage Focus

  • Seed (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Enterprise Applications
  • Information Technology
  • Software
  • Health Care
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lightchain Capital frequently co-invest with?

CS
North America, New Jersey, United States, Morristown
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Jefferies
North America, New York, United States, New York
Co-Investments: 1
Cobro Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2
Bio-Rad Laboratories
North America, California, United States, Hercules
Co-Investments: 1
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 2
Pelion Venture Partners
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Willett Advisors LLC
North America, New York, United States, New York
Co-Investments: 1
EC
North America, Massachusetts, United States, Boston
Co-Investments: 1
RC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Lightchain Capital?

Predicta Biosciences

Boston, Massachusetts, United States

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsLife ScienceTherapeutics
Series AOct 1, 2025
Amount Raised: $23,400,000
Wugen

St Louis, Missouri, United States

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

BiotechnologyTherapeutics
Series CAug 27, 2025
Amount Raised: $115,000,000
Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJan 8, 2025
Amount Raised: $105,000,000
SimpleRose

Saint Louis, Missouri, United States

SimpleRose is a technology company that allows customers to optimize and accelerate decision-making.

Enterprise ApplicationsInformation TechnologySoftware
Series AApr 6, 2023
Amount Raised: $23,001,264
AI Proteins

Boston, Massachusetts, United States

AI Proteins is a biotechnology company that focuses on designing and engineering of synthetic miniprotein therapeutics.

Artificial Intelligence (AI)BiotechnologyTherapeutics
SeedNov 3, 2022
Amount Raised: $18,200,000
NextRNA Therapeutics

Cambridge, Massachusetts, United States

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

BiotechnologyHealth CareTherapeutics
Series AMar 1, 2022
Amount Raised: $46,800,000
SimpleRose

Saint Louis, Missouri, United States

SimpleRose is a technology company that allows customers to optimize and accelerate decision-making.

Enterprise ApplicationsInformation TechnologySoftware
SeedOct 10, 2018
Amount Raised: $24,000,000